Keywords: rhone-poulenc, rorer, granocyte, perhaps, potent, neupogen, granulocyte
Rhone-Poulenc Rorer's Granocyte Perhaps More Potent Than Neupogen
Article | 18 December 1995
- Rhone-Poulenc Rorer's granulocyte colony stimulating factor drug Granocyte (lenograstim) may be 25% more potent than Amgen-Roche's Neupogen (filgrastim) in mobilizing stem ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
